Supplementary Figure 1 and 2 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma

1.Western blot analysis of the cleaved caspase-3 and p53 pathways in Ceritinib and Ribociclib treated cells. 2.Combination ALK and CDK 4/6 inhibition leads to enhanced G0/G1 arrest.